RagA, but Not RagB, Is Essential for Embryonic Development and Adult Mice  by Efeyan, Alejo et al.
Developmental Cell
Short ArticleRagA, but Not RagB, Is Essential
for Embryonic Development and Adult Mice
Alejo Efeyan,1,2,3,4,5 Lawrence D. Schweitzer,1,2,3,4,5 Angelina M. Bilate,1 Steven Chang,1,2,3,4,5 Oktay Kirak,1,6
Dudley W. Lamming,1,2,3,4,5,7 and David M. Sabatini1,2,3,4,5,*
1Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA
2Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, MA 02142, USA
3Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA
4David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
5Howard Hughes Medical Institute, MIT, Cambridge, MA 02139, USA
6Present address: The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
7Present address: School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA
*Correspondence: sabatini@wi.mit.edu
http://dx.doi.org/10.1016/j.devcel.2014.03.017SUMMARY
The mechanistic target of rapamycin complex 1
(mTORC1) integrates cues from growth factors and
nutrients to control metabolism. In contrast to the
growth factor input, genetic disruption of nutrient-
dependent activation of mTORC1 in mammals re-
mains unexplored. We engineered mice lacking
RagA and RagB genes, which encode the GTPases
responsible for mTORC1 activation by nutrients.
RagB has limited expression, and its loss shows no
effects on mammalian physiology. RagA deficiency
leads to E10.5 embryonic death, loss of mTORC1
activity, and severe growth defects. Primary cells
derived from these mice exhibit no regulation of
mTORC1 by nutrients and maintain high sensitivity
to growth factors. Deletion of RagA in adult mice is
lethal. Upon RagA loss, a myeloid population ex-
pands in peripheral tissues. RagA-specific deletion
in liver increases cellular responses to growth
factors. These results show the essentiality of
nutrient sensing for mTORC1 activity in mice and
its suppression of PI3K/Akt signaling.
INTRODUCTION
The mechanistic target of rapamycin (mTOR) is a serine-
threonine kinase that, as part of mTOR complex 1 (mTORC1),
orchestrates cell growth and anabolism (Laplante and Sabatini,
2012). In mammals, mTORC1 activity is tightly controlled by
growth factors, which trigger a cellular cascade that culminates
in mTORC1 kinase activation. Nutrient abundance regulates
mTORC1 through the activation of the Rag GTPases, which
recruit mTORC1 to the lysosomal surface, an essential step for
its kinase activation by growth factors. Hence, both inputs—
growth factors and nutrients—must be present for maximal
mTORC1 activity.
Germline deletion of the Raptor or mTOR genes in mice
demonstrates the requirement for mTORC1 activity for mam-Devemalian development (Gangloff et al., 2004; Guertin et al., 2006;
Murakami et al., 2004). In addition, acute deletion of Raptor in
the tissues of adult mice showed that loss of mTORC1 activity
in mammals has profound consequences (Polak and Hall,
2009). The physiological importance of growth factor-dependent
regulation of mTORC1 in mammals is well established (Goorden
et al., 2011). We have previously reported that constitutive RagA
activity in mice leads to a neonatal energetic crisis and death
(Efeyan et al., 2013), indicating that, unlike constitutive activation
by growth factor signaling, constitutive activation of mTORC1 by
the nutrient sensing pathway (i.e., amino acids and glucose) is
compatible with embryonic development but has a detrimental
role soon after birth. However, the requirement of the nutrient
sensing machinery in mammals remains unexplored (reviewed
in Efeyan and Sabatini, 2013; Laplante and Sabatini, 2012).
Here, we show that abrogation of nutrient-dependent activa-
tion of mTORC1, by means of genetic loss of the Rag GTPases,
leads to embryonic lethality. Conditional deletion of RagA (but
not RagB) in adult mice strongly suppresses mTORC1 activity
and leads to PI3K/Akt activation. Furthermore, acute deletion
of RagA in adult mice is also lethal and leads to the expansion
of a monocytic-like population, which colonizes multiple organs.
RESULTS
RagA Is Essential for mTORC1 Activation and for
Embryonic Development
We have previously generated mice conditionally expressing a
constitutively active form of RagA (RagAGTP), by means of a
Lox-STOP-Lox strategy (Efeyan et al., 2013). In the absence of
the Cre-recombinase, the RagASTOP allele is not expressed
and is functionally null, and we took advantage of this prerecom-
bined null allele to determine the consequences of the absence
of the RagA gene in mice. While RagASTOP/+ mice were viable
and seemingly normal, RagASTOP/STOP mice succumbed embry-
onically. We also generated conventional RagA knockout mice
bymeansof generating aRagAfloxed (RagAfl/fl) allele (FigureS1A
available online). We then crossed RagAfl/+ mice with CMV-
Cre transgenic mice, which delete RagA in the germline
(referred to as RagAD or ‘‘deleted’’ allele). Through intercrosses
of RagASTOP/+ mice or RagAD/+ mice, we observed that deletionlopmental Cell 29, 321–329, May 12, 2014 ª2014 Elsevier Inc. 321
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Figure 1. Embryonic Lethality of RagA
KO Mice
(A) Representative pictures of E10.5 embryos of
the indicated RagA genotype (see also Figure S1).
(B) Whole-embryo protein extracts from RagA+/+,
RagA+/, and RagA/ littermates were analyzed
by immunoblotting for the indicated proteins.
(C) RagAfl/fl MEFs were infected with control
(Ad-Ø) or adenovirus encoding the Cre re-
combinase (Ad-Cre), starved for amino acids for
1 hr, and, where indicated, restimulated for 10min.
Total protein extracts were then analyzed by
immunoblotting for the indicated proteins.
(D) Total cell count of cells infected as in (C) was
monitored for 4 days. Data are mean ± SD; n = 3.
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(Table S1). Embryos lacking the RagA gene showed profound
developmental aberrations, including an open neural tube and
severely decreased size, and a proportion was evidently reab-
sorbed by 10 days (Figures 1A and S1B). Consistent with a key
role for RagA in the activation of mTORC1 in vivo, mTORC1
activity was severely reduced in total protein extracts of embryos
lacking the RagA gene (Figure 1B; additional examples in Fig-
ure S1C). It is unlikely that this reflects an overall decrease in
cellular signaling secondary to reabsorption, as protein extracts
were prepared from embryos with heartbeats, and furthermore,
increased Akt activity, revealed by its phosphorylation at Thr308
or Ser473, was evident in RagA-deficient embryos (Figure 1B).322 Developmental Cell 29, 321–329, May 12, 2014 ª2014 Elsevier Inc.Indeed, when two different RagA null
E10.5 embryos were obtained in the
same litter, one alive and one reabsorbed,
the former showed high Akt activity,
whereas the latter showed decreased
Akt activity, when both were compared
withwild-type (WT) embryos (Figure S1C).
This result also shows the strong negative
regulation that mTORC1 has on Akt acti-
vation, as shown previously (Harrington
et al., 2004; Haruta et al., 2000; Um
et al., 2004). RagB levels are very low or
absent in most tissues of adult mice,
and also in embryos. Interestingly, em-
bryos lacking RagA frequently showed
upregulation of RagB protein (Figures 1B
and S1C), suggesting the existence of a
mechanism that tries to maintain the total
level of the Rag GTPases.
We established primary mouse embry-
onic fibroblasts (MEFs) cultures from
RagAfl/+ and RagAfl/fl E13.5 embryos
and deleted the RagA gene by infecting
the cells with adenovirus encoding Cre-
recombinase. Acute loss of RagA led to
partial loss of mTORC1 activation by
amino acids or glucose, together with
activation of Akt (Figures 1C, S1D, and
S1E). This signaling defect was accom-
panied by a moderate decrease inproliferation rate (Figure 1D). As nondeleted, RagAfl/fl cells
outcompeted RagAD/D cells, attempts to establish cell lines
lacking RagA gene were not successful with this approach.
Nutrient-Insensitive mTORC1 Activity in RagA-Deficient
Cells in Culture
To overcome out-competition of nonrecombining RagAfl/fl MEFs
in the adenovirus-Cre-based approach, we attempted to obtain
RagA/ cells by culturing RagA E10.5 genetically deficient
embryos. We readily obtained cultures from RagA-expressing
embryos, but the proportion of RagA-deficient cell lines that sur-
vived initial in vitro conditions was very low. In addition, longer
times in culture were necessary for RagA-deficient cells to start
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Figure 2. RagA Null Cells Exhibit Nutrient-Independent mTORC1 Activity
(A) Absence of RagA protein in surviving RagA/ cell lines.
(B) RagA/ cells maintain high sensitivity to growth factor deprivation, as determined by immunoblotting for mTORC1 and Akt activation markers.
(C) RagA/ cells exhibit constitutive mTORC1 activity regardless of nutrient (amino acid or glucose) deprivation, as determined by immunoblotting for mTORC1
activation markers from whole-cell extract after amino acid or glucose starvation of cells followed by restimulation.
(D) mTOR localization by immunofluorescence. In RagA+/ cells, amino acid deprivation causes mTOR to localize to a diffuse puncta throughout the cytoplasm.
Readdition of amino acids leads to mTOR shuttling to the lysosomal surface and colocalizing with the lysosomal protein Lamp2. In contrast, RagA/ cells show
mTOR constitutively diffuse throughout the cytoplasm, regardless of amino acid levels.
(E) Constitutive mTORC1 activity, regardless of amino acid levels, can be reversed by reconstituting Rag activity. RagA/ cells were infected with a lentivirus
encoding RagBWT protein, and after starvation and restimulation with amino acids, whole-cell protein extracts were immunoblotted for the indicated proteins (see
also Figure S2).
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pendent cell lines. As in the embryos, RagA-deficient cells
showed a moderate upregulation of RagB (Figures 2A, S2A,
and S2B). mTORC1 activity was inhibited by deprivation ofDeveamino acids, glucose, or growth factors (as determined by phos-
phorylation of S6K1 and 4EBP1) in RagA-proficient cells. In
contrast, in RagA-deficient cells, mTORC1 activity was insen-
sitive to deprivation of either amino acids or glucose butlopmental Cell 29, 321–329, May 12, 2014 ª2014 Elsevier Inc. 323
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This suggests that loss of RagA led to the emergence of a
RagA-independent mechanism of maintaining mTORC1 activity
that contrasts with the very low mTORC1 activity of Ragulator-
deficient cells (Sancak et al., 2010). It is unlikely that another
kinase, in RagA-deficient cells, is responsible for phosphory-
lating S6K1 and 4EBP1, as inhibition of mTORC1with rapamycin
ablated the phosphorylation of S6K1 (Figure S2C). Furthermore,
knockdown of the Rheb GTPase, responsible for stimulating the
mTORC1 kinase activity and the endpoint of growth factor input,
completely ablated mTORC1 activity in RagA/ cells (Fig-
ure S2D). RagA-deficient cells also showed a marked increase
in Akt activation, as determined by the phosphorylation of
Thr308 and Ser473 on Akt, which likely helps to compensate
for the decrease in mTORC1 caused by RagA loss (Figure 2B).
In addition, increased levels of total IRS1 and a strong activation
of the MAPK kinase pathway were also evident in these cells
(Figure 2B), indicating that activation of growth factor signaling
is not restricted to PI3K/Akt. We initially hypothesized that the in-
crease in the abundance of RagB could rescue the loss of RagA
in mTORC1 activation, allowing mTORC1 recruitment to the
outer lysosomal surface, the site of mTORC1 activation. Incon-
sistent with this possibility, RagC, the obligate partner of RagA
or RagB, did not colocalize with the lysosomal marker Lamp2
(Figure S2E), suggesting that a mild elevation in RagB levels
could not overcome loss of RagA. Addition of amino acids in
RagA-proficient cells recruited mTORC1 to the outer lysosomal
surface (Sancak et al., 2008, 2010). In contrast, in cells lacking
RagA, mTORC1 remained diffuse throughout the cytoplasm
and did not colocalize with Lamp2 regardless of the presence
or absence of amino acids (Figure 2D). To discard a qualitatively
different lysosomal morphology that could mislead the interpre-
tation of the results, we performed immunofluorescence staining
for another lysosomal marker, Lamp1, in cells fixed in methanol.
While methanol fixation precludes staining for mTORC1, it is
optimal for preserving membrane structures and for the staining
of membrane-bound proteins. We observed a similar lysosomal
morphology in RagA-proficient and RagA-deficient cells stained
for Lamp1 (Figure S2F). This suggested that a RagA-indepen-
dent mechanism for maintaining mTORC1 activity was at work.
In order to explore the reversibility of this phenomenon, we
reconstituted Rag activity in RagA/ cells by stably expressing
RagB from a lentiviral plasmid. In these cells, mTORC1 activity
was readily inhibited by amino acid withdrawal, and readdition
of amino acids led to mTORC1 activation, thus correcting the
insensitivity of RagA-deficient cells (Figure 2E). In agreement
with this, forced expression of RagB allowed mTORC1 recruit-
ment to the lysosome surface in the presence, but not in the
absence, of amino acids (Figure S2G). In addition, expression
of RagB in RagA/ cells partially suppressed the activation of
Akt (Figure S2H). The similar reversion of the nutrient-dependent
regulation of mTORC1 activity was observed when we trans-
duced RagA (Figure S2I), suggesting that overall Rag activity,
rather than specific potential functions of RagA or RagB, was
responsible for this rescue.
To analyze the consequences of the lack of regulation of
mTORC1 activity by nutrients in RagA-deficient cells, we
performed prolonged amino acid starvation and determined
the extent to which autophagy, a cellular process of recycling324 Developmental Cell 29, 321–329, May 12, 2014 ª2014 Elsevier Incytoplasmic proteins and organelles that is regulated by
mTORC1 (Mizushima et al., 2008), was affected in RagA-
deficient cells. A 20 min amino acid starvation was sufficient to
inhibit mTORC1 activity in RagA-proficient cells. However, pro-
longed amino acid starvation (i.e., at least 2 hr) was necessary
for triggering inhibition of mTORC1 activity in RagA-deficient
cells (Figure S2J). Interestingly, readdition of amino acids for
10min resulted in nomTORC1 activation in RagA-deficient cells,
showing that the mechanism leading to mTORC1 activation in
the absence of RagA does not rely on a fast signal transduction
cascade (Figure S2K). When we looked at the regulation of auto-
phagy markers, we observed that phosphorylation of the
mTORC1 target ULK1 was also affected with slower kinetics in
RagA-deficient cells (Figure S2J). P62, which is degraded during
the process of autophagy, decreased in RagA-proficient and
RagA-deficient cells, suggesting that RagA null are able to
trigger autophagy upon prolonged amino acid starvation. In
agreement with this, all cells, regardless of RagA status, showed
a similar rate of death upon long nutrient withdrawal from the
culture medium (data not shown).
Deletion of the RagB Gene in Mice Is Innocuous
In order to determine the contribution of RagA versus RagB in the
regulation of mTORC1 activity in mice, we generated RagB
floxed mice by introducing LoxP sites flanking the endogenous
exon 3 of RagB gene, encoded on the X chromosome (Fig-
ure S3A). RagBfloxed mice were crossed with CMV-Cre trans-
genicmice to achieve complete deletion of RagB in the germline.
Intercrosses of RagB+/ mice produced RagB+/+, RagB+/, and
RagB/ (or male RagB/0) offspring with normal Mendelian
ratios, suggesting that loss of RagB has no obvious conse-
quences for embryonic development or for surviving the first
weeks of life. Deletion of the RagB gene was confirmed in
RagB/0 mice in whole-brain extracts (Figure S3B). A redundant
and hence compensatory role of RagA in the context of RagB null
mice was very likely to occur, as RagA has a widespread pattern
of expression in most tissues and is more abundant than RagB in
tissues in which RagB is expressed to detectable levels, as in the
brain (Figure S3B). Overall mTORC1 activity was not regulated in
whole-mouse brain extracts upon fasting and refeeding, and
more importantly, it was also not affected by loss of RagB
(Figure S3C). In liver extracts, mTORC1 activity was equally
regulated by fasting/refeeding in RagB+/0 and RagB/0 mice. It
is possible that RagB plays specialized roles in the brain or in
other organs, but nevertheless, the undetectable effects of its
deletion are in sharp contrast to the deep signaling impairment
and embryonic death seen in RagA-deficient mice.
Germline Deletion of RagA and RagB
In order to ablate all RagA/B activity and determine if RagB was
providing some level of compensation in the context of RagA
loss, we generated RagA/B double knockout mice (RagA/B
DKO). At E10.5, the developmental time point at which RagA
knockout embryos were found with profound defects but were
generally still alive, RagA/B DKO embryos were found in
low proportions and undergoing reabsorption (Table S2). This
suggests that in the absence of RagA, increased levels of
RagB can sustain some mTORC1 activity in early stages of
embryonic development, and also provides an explanation forc.
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Figure 3. Defective mTORC1 Activation in RagA-Deficient Livers
(A) Mice of the indicated genotypes were starved overnight and then either refed or injected with glucose or insulin for the indicated times. Whole-protein extracts
from liver were immunoblotted for indicated proteins.
(B) Samples as in (A) were analyzed by immunohistochemistry with anti-phospho-S235/236 S6 (see also Figure S3).
(C) Liver samples as in (A) were immunoblotted for Akt phosphorylation targets.
(D) RNA was extracted from control and RagAfl/fl;Alb-Cre+ mice, and mRNA expression of the indicated genes was determined by quantitative real-time PCR
(mean ± SEM, n = 5 (WT fasted), 3 (WT refed), 7 (KO fasted), 7 (KO refed).
(E) Glucose tolerance and insulin tolerance tests performed in WT and RagA liver KO mice (mean ± SEM). *p < 0.05; **p < 0.01.
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embryos (E3.5 and E6.5, respectively; Gangloff et al., 2004;
Guertin et al., 2006; Murakami et al., 2004). Ragulator null
embryos, which ablate all Rag activity, but not other inputs to
mTORC1, also succumbed before E10.5 (Teis et al., 2006),
further suggesting a mild compensatory effect of RagB in
RagA-deficient embryos.
Deletion of RagA and RagB in Hepatocytes
We analyzed the effect of acute loss of RagA in mouse liver,
as it is a key organ for coordinating fasting/feeding responses
and contributes greatly to glucose homeostasis. We deleted
RagA and RagB genes in mouse livers in which Cre recombi-
nase was under the expression of the albumin promoter (Alb-
Cre) (Postic et al., 1999). Deletion of RagA in liver led to robust
suppression of mTORC1 activity upon overnight fasting and
refeeding, as seen by abrogated phosphorylation of mTORC1
targets in immunoblots (Figures 3A and S3D). Profound effectsDeveon mTORC1 activation were also observed when glucose or
insulin were injected, showing the essentiality of RagA up-
stream of mTORC1 to allow its activation by the other main
activator of mTORC1, growth factors. Similar results were
observed when we assessed the phosphorylation of S6 by
immunohistochemistry (Figure 3B). Isolated groups of cells in
RagAfl/fl;Alb-Cre+ mice showed an increase in phospho-S6
upon refeeding, which were clearly identified as hepatocytes
at higher magnification (Figure S3E) and may be escapers
from Cre-mediated recombination. This explains, together
with nonhepatocyte cells present in the liver, the residual
levels of RagA in western blots. When the same fasting/
refeeding experiment was performed in old (>1 year) mice,
regulation of mTORC1 activity was similar to that of wild-
type mice (Figure S3F), and to a large extent, so were levels
of the RagA protein, suggesting the possibility that a propor-
tion of cells that had escaped Cre-mediated DNA recombina-
tion increased with time.lopmental Cell 29, 321–329, May 12, 2014 ª2014 Elsevier Inc. 325
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Figure 4. Acute Deletion of RagA in Adult Mice
(A) Control (RagAfl/+;UBC-CreER, RagAfl/+;UBC-CreER+, RagAfl/fl;UBC-CreER) and RagAfl/fl;UBC-CreER+micewere injected with tamoxifen for Cre activation,
and their weight was monitored every week (mean ± SEM).
(B) Kaplan-Meier survival curves after tamoxifen injection of control (RagAfl/+;UBC-CreER, RagAfl/+;UBC-CreER+, RagAfl/fl;UBC-CreER) versus RagAfl/fl;
UBC-CreER+ mice.
(C) Representative hematoxylin and eosin (H&E)-stained sections of small intestine from RagAfl/fl;UBC-CreER mice and RagAfl/fl;UBC-CreER+ mice 2 weeks
after start of tamoxifen injections. Arrowhead indicates apoptotic figures.
(D) Representative H&E-stained sections spleen and bone marrow from RagAfl/fl;UBC-CreER mice and RagAfl/fl;UBC-CreER+ mice 2 weeks after start of
tamoxifen.
(E) Bone marrow cells were harvested, immunostained, and analyzed by flow cytometry. Dot plots show the cells gated on Lin (CD3/CD19/Ter119/NK1.1) and
are representative of onemouse out of 4–5. Gr-1 andCD11b staining was used to identifymonocytes. Graph shows the quantification of the proportion of resident
(or patrolling) BM monocytes (determined by CD11b+ Gr-1low). CD11b+ Gr-1high corresponds to inflammatory monocytes.
(legend continued on next page)
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protein (Figures 3A and S3D), and in order to determine the
impact of complete loss of Rag function, we generated RagAfl/fl;
RagBfl/fl (or fl/0);AlbCre+ mice (RagA/B DKO). In comparison to
RagA KO livers, RagA/B DKO livers showed a further decrease
in mTORC1 activity, again with hyperactivation of Akt (Fig-
ure S3G). This suggests that, as in embryos, RagB partially
compensates for RagA loss in the activation of mTORC1.
We searched for the consequences of reduced mTORC1
activity and increased PI3K/Akt activities in RagA/ livers on
fasting/refeeding responses. FoxO1/3 and GSK3b, downstream
phosphorylation targets of Akt involved in the regulation of
glucose homeostasis, showed increased phosphorylation from
fasted/refed RagA/ livers (Figure 3C). As expected from the
increased inhibitory phosphorylation of the FoxO transcription
factors, we observed transcriptional changes in genes regu-
lated by fasting/refeeding via the PI3K/Akt/FoxO axis, such as
PEPCK, glucose-6-phosphatase, and glucokinase (Zhang
et al., 2006) (Figure 3D). This correlated with a mild reduction in
ad libitum blood glucose levels (Figure S3H) in young
RagAfl/fl;AlbCre+ mice. While the mice were equally tolerant to
glucose in a glucose tolerance test (GTT), an increased reduction
in glycaemia upon injection of insulin in an insulin tolerance test
(ITT) was observed (Figure 3E), suggesting that loss of RagA
leads to a better response to insulin in vivo. Together with the
cell-autonomous effects on Akt activation in cultured RagA null
cells, these findings provide support for the efficiency of dieting
(i.e., reduced nutrient intake) and pure mTORC1 inhibitors to
control overactivation of mTORC1, and for ameliorate insulin
resistance and metabolic syndrome.
Deletion of RagA in Adult Mice Is Lethal
Because deletion of RagA in the germline led to embryonic
lethality, precluding the analysis of adult RagA-deficient mice,
we took advantage of a tamoxifen-inducible Cre-recombinase
driven by a ubiquitous promoter (UBC-CRE-ERT2, also denoted
herein as UBC-CreER) (Ruzankina et al., 2007), to achieve full-
body acute deletion of RagA in adult mice. Injecting mice with
tamoxifen caused excision of RagA and decreased mTORC1
activity in several tissues (Figures S4A and S4B). RagAfl/fl;
UBC-CreER+ (RagA-iKO) mice transiently lost 20% body
weight within 1 week (Figure 4A). More than 50% of RagA-iKO
mice succumbedwithin 2–3weeks after the start of tamoxifen in-
jections (Figure 4B). The time of death suggested atrophy of the
small intestine, which has also been reported for full-body
RaptorD/D mice (Hoshii et al., 2012). Indeed, the small intestine
in RagA-iKOmice showed frequent apoptotic figures (Figure 4C).
In addition, RagA-iKO showed a prominent accumulation of
cells that resembledmonocytes in spleen and bonemarrow (Fig-
ure 4D). Immunostaining using antibodies against monocyte sur-
face markers confirmed the increase proportion of monocytes in
bone marrow and spleen of RagA-iKO compared to their wild-
type counterparts (Figure 4E). We then assessed the proliferative(F) Representative H&E-stained sections of indicated tissues from RagAfl/fl;UB
injections. Black arrowhead indicates normal tissue; white arrowhead indicates m
(G) Representative H&E-stained sections of liver and spleen from wild-type m
RagAfl/fl ;UBC-CreER+ mice, injected with tamoxifen 6 weeks after bone marrow
white arrowhead indicates monocytic population. Bar indicates 40 mm.
Devestatus of this lineage by in vivo bromodeoxiuridine (BrdU) incor-
poration. A population of CD11blow Gr-1+ CD115 cells from
bone marrow of RagA-iKO incorporated nearly twice as much
BrdU as did control mice (Figure S4C). The rapid expansion of
monocytes was accompanied by a profound reduction in B
lymphocytes and/or their progenitors (Figure S4D), as shown
previously for Raptor-deleted mice (Hoshii et al., 2012; Kalaitzi-
dis et al., 2012).
The rapid death (within 2–3 weeks) of RagA-iKOmice presum-
ably due to intestinal atrophy was partially penetrant. In the
40% of mice that survived acute deletion of the RagA gene,
the expansion of myeloid cells that could be already detected
2 weeks after tamoxifen, continued to spread in peripheral tis-
sues. It was evident in liver, spleen, and meninges (Figure 4F)
and in many cases was so severe that mice had to be sacrificed.
This disease was histopathologically reminiscent of histiocytic
sarcoma, the murine equivalent of monocytic leukemia, and
did not stem from escapers from the action of the Cre recombi-
nase, as the deletion of the RagA gene was confirmed by PCR
(Figure S4E). Furthermore, spleen and purified splenocytes, as
well as liver from treated RagA-iKO mice, showed barely detect-
able levels of RagA protein and low mTORC1 activity (Fig-
ure S4F). In addition, cultured macrophages obtained from
RagA-iKO mice 2 weeks after starting tamoxifen treatment
showed reduced levels of RagA, reduced mTORC1 activation,
and increased Akt activity (Figure S4G).
We also performed bone marrow reconstitution experiments
to analyze this myeloid expansion without the detrimental effects
of RagA deletion in other tissues, such as the small intestine.
Irradiated wild-type hosts were reconstituted with bone marrow
cells from either RagAfl/fl;UBC-CreER+ or RagAfl/fl;UBC-CreER
mice and treated with tamoxifen after engraftment. Tamoxifen
injections in bone marrow chimeras did not lead to the acute
(within 2–3 weeks) death observed in full-body RagAfl/fl;UBC-
CreER+mice. However, RagAfl/fl;UBC-CreER+ chimeras recapit-
ulated the splenomegaly (Figure S4H) and the monocyte
expansion in bone marrow and peripheral tissues (Figure 4G)
that was observed in full-body RagA-iKO mice and that limited
their survival.
DISCUSSION
Absence of RagB in embryos and mice did not show any conse-
quences, had no obvious phenotypes, and were fertile. This is
consistent with the limited expression of the RagB gene in
most tissues and with the higher expression of RagA throughout
the body. In contrast, RagA null embryos succumbed
within 10–11 days of development, with profound defects
and a severe reduction in mTORC1 activity. On the one hand,
RagA-deficient embryos demonstrate the requirement of the
nutrient dependent input upstream of mTORC1 for its activity.
The similar onset of lethality with Rheb-deficient embryos
(Goorden et al., 2011) indicates that both major regulators ofC-CreER mice and RagAfl/fl;UBC-CreER+ mice 3.5 months after tamoxifen
onocytic population.
ice reconstituted with bone marrow from RagAfl/fl ;UBC-CreER mice and
reconstitution (see also Figure S4). Black arrowhead indicates normal tissue;
lopmental Cell 29, 321–329, May 12, 2014 ª2014 Elsevier Inc. 327
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in the onset of death between RagA null and mTOR null (or
Raptor null) embryos can be explained by residual mTORC1
activity in the absence of RagA, which may be due to increased
levels of RagB. Finally, the relatively high levels of RagA in all
tissues can explain the lack of phenotypes associated with
RagB deletion.
The inability to acutely induce deletion of RagA in MEFs
prompted us to establish cell lines from E10.5 embryos geneti-
cally deficient for RagA. To our surprise, instead of having
residual mTORC1 activity, these lines grew with comparable
levels of mTORC1 activity that did not respond to acute changes
in nutrients, but were able to regulatemTORC1 via slow, perhaps
transcriptionally regulated mechanisms. Interestingly, it was
recently shown that Rheb null cells also retain significant levels
of mTORC1 activity in culture (Groenewoud et al., 2013). In
RagA null cells, mTORC1 did not localize at the lysosomal
surface, indicating that cells underwent an adaptation that
enabled high mTORC1 activity in a Rag-independent manner
and that involved an upregulation of the growth factor input.
The effects of the liver-specific ablation of Rag function on
mTORC1 activity were severe and comparable to Raptor loss
(Sengupta et al., 2010). Deletion of RagA led to activation of
PI3K/Akt and downstream inhibition of the FoxO1/3 transcription
factors. Because the FoxO transcriptional program increases de
novo glucose production, glycaemia in ad libitum hepatocyte-
specific RagA null mice was mildly lower. This result has impli-
cations in the context of metabolic syndrome therapeutic
approaches, as nutrient overload has a strong correlation with
the onset of type 2 diabetes (Wang et al., 2011). The data
suggest that Rag-dependent regulation of mTORC1 may play
a significant role in the correction of insulin resistance and
glucose homeostasis observed when nutrient intake is lowered.
Interestingly, the biguanide metformin, used to control glucose
output in the liver, has been reported to inhibit, among other
pathways, the Rag GTPases (Kalender et al., 2010). The data
presented herein are consistent with at least part of the beneficial
effects of metformin being related to its effects on the regulation
of Rag-dependent mTORC1 activation.
Our work shows that deletion of the RagA gene in adult mice
leads to many changes similar to those resulting from the loss
of the key mTORC1 component Raptor. This is highlighted by
the rapid death following tamoxifen injection in adult RagAfl/fl;
UBC-CreER+ mice. Deletion of RagA leads to a rapid expansion
of a similar population that is found in meninges, liver, and other
tissues and limits survival. PTEN deletion, which leads to Akt
activation, can also lead to different types of myeloproliferative
disease (Tesio et al., 2013; Yilmaz et al., 2006), again linking
reduced mTORC1 activity with increased PI3K/Akt activity.
The solid body of evidence pointing toward mTORC1 as a key
regulator of aging is supported by the antiaging and antitumoral
effects of rapamycin, a specific, albeit incomplete, mTORC1
inhibitor. The realization that rapamycin can also block mTORC2
(Lamming et al., 2012; Sarbassov et al., 2006), as mTOR-cata-
lytic inhibitors do (Laplante and Sabatini, 2012), has spurred
interest in the development of pure (and complete) mTORC1
inhibitors, that spare mTORC2 as an antiaging strategy. The
results presented herein provide support for beneficial effects
of such compounds on insulin sensitivity.328 Developmental Cell 29, 321–329, May 12, 2014 ª2014 Elsevier InEXPERIMENTAL PROCEDURES
Generation of RagA and RagB Knockout Mice
All animal studies and procedures were approved by the MIT Institutional
Animal Care and Use Committee. RagA locus was targeted by introducing
LoxP sites and frt-neomycin-frt cassette flanking RagA exon (a map of the
targeting allele is shown in Figure S1A). Similarly, the RagB locus was targeted
by introducing LoxP sites flanking exon 3 (a map of the RagB targeting allele is
shown in Figure S3A). RagASTOP allele was previously described (Efeyan et al.,
2013).
Treatments of Mice
Fasting was performed from 6 p.m. to 9 a.m., and thenmice were injected with
30% w/v glucose in PBS 100 ml per 30 g mouse, allowed to feed ad libitum, or
injected intraperitoneally with 11.25 ml of insulin (HumulinR, Lilly) dissolved in
5 ml of PBS at a dose of 100 ml per 30 g mouse.
Treatments of MEFs
Subconfluent cells were rinsed twice and incubated in RPMI without amino
acids and/or glucose and supplemented with 10% dialyzed fetal bovine
serum, as described previously (Sancak et al., 2008). Stimulation with glucose
(5 mM) or amino acids (concentration as in RPMI) was performed for 10 min.
For serum withdrawal, cells were rinsed twice in serum-free Dulbecco’s
modified Eagle’s medium (DMEM) and incubated in serum-free DMEM for
the indicated times; 100 nM was used for insulin stimulation.
Statistical Analyses
For Kaplan-Meier survival curves, comparisons were made with the log-rank
Mantel-Cox method. For quantitative real-time PCR analyses, measurements
of glycemia, and other comparisons between pairs, nonparametric t tests were
performed.
See Supplemental Experimental Procedures for details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.devcel.2014.03.017.
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